193 related articles for article (PubMed ID: 27518436)
21. Long-Term Administration of Fibroblast Growth Factor 21 Prevents Chemically-Induced Hepatocarcinogenesis in Mice.
Xu P; Zhang Y; Wang W; Yuan Q; Liu Z; Rasoul LM; Wu Q; Liu M; Ye X; Li D; Ren G
Dig Dis Sci; 2015 Oct; 60(10):3032-43. PubMed ID: 26003555
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice.
Wang Z; Yan J; Lin H; Hua F; Wang X; Liu H; Lv X; Yu J; Mi S; Wang J; Hu ZW
Hepatology; 2013 May; 57(5):1869-81. PubMed ID: 23299825
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of DEN-induced liver tumourigenesis in hepatocyte-specific Lass2-knockout mice coincident with upregulation of the TGF-β1-Smad4-PAI-1 axis.
Chen L; Lu X; Zeng T; Chen Y; Chen Q; Wu W; Yan X; Cai H; Zhang Z; Shao Q; Qin W
Oncol Rep; 2014 Feb; 31(2):885-93. PubMed ID: 24337404
[TBL] [Abstract][Full Text] [Related]
24. Timp3 deficiency affects the progression of DEN-related hepatocellular carcinoma during diet-induced obesity in mice.
Casagrande V; Mauriello A; Anemona L; Mavilio M; Iuliani G; De Angelis L; D'Onofrio M; Arisi I; Federici M; Menghini R
Acta Diabetol; 2019 Dec; 56(12):1265-1274. PubMed ID: 31292722
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated mitogen-activated protein kinase.
Nakagawa H; Hirata Y; Takeda K; Hayakawa Y; Sato T; Kinoshita H; Sakamoto K; Nakata W; Hikiba Y; Omata M; Yoshida H; Koike K; Ichijo H; Maeda S
Hepatology; 2011 Jul; 54(1):185-95. PubMed ID: 21488081
[TBL] [Abstract][Full Text] [Related]
26. Caspase-2 protects against oxidative stress in vivo.
Shalini S; Puccini J; Wilson CH; Finnie J; Dorstyn L; Kumar S
Oncogene; 2015 Sep; 34(38):4995-5002. PubMed ID: 25531319
[TBL] [Abstract][Full Text] [Related]
27. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
[TBL] [Abstract][Full Text] [Related]
28. Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis.
Sakurai T; He G; Matsuzawa A; Yu GY; Maeda S; Hardiman G; Karin M
Cancer Cell; 2008 Aug; 14(2):156-65. PubMed ID: 18691550
[TBL] [Abstract][Full Text] [Related]
29. Histology, bioenergetics and oxidative stress in mouse liver exposed to N-diethylnitrosamine.
Santos NP; Pereira IC; Pires MJ; Lopes C; Andrade R; Oliveira MM; Colaço A; Peixoto F; Oliveira PA
In Vivo; 2012; 26(6):921-9. PubMed ID: 23160673
[TBL] [Abstract][Full Text] [Related]
30. Berberine and S allyl cysteine mediated amelioration of DEN+CCl4 induced hepatocarcinoma.
Sengupta D; Chowdhury KD; Sarkar A; Paul S; Sadhukhan GC
Biochim Biophys Acta; 2014 Jan; 1840(1):219-44. PubMed ID: 23999088
[TBL] [Abstract][Full Text] [Related]
31. Loss of hepatic Sirt7 accelerates diethylnitrosamine (DEN)-induced formation of hepatocellular carcinoma by impairing DNA damage repair.
Kim Y; Kang BE; Gariani K; Gariani J; Lee J; Kim HJ; Lee CW; Schoonjans K; Auwerx J; Ryu D
BMB Rep; 2024 Feb; 57(2):98-103. PubMed ID: 38303560
[TBL] [Abstract][Full Text] [Related]
32. Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity.
Guo Y; Wang W; Wang J; Feng J; Wang Q; Jin J; Lv M; Li X; Li Y; Ma Y; Shen B; Zhang J
Hepatology; 2013 Jan; 57(1):140-51. PubMed ID: 22903704
[TBL] [Abstract][Full Text] [Related]
33. RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis.
Mayhew CN; Carter SL; Fox SR; Sexton CR; Reed CA; Srinivasan SV; Liu X; Wikenheiser-Brokamp K; Boivin GP; Lee JS; Aronow BJ; Thorgeirsson SS; Knudsen ES
Gastroenterology; 2007 Sep; 133(3):976-84. PubMed ID: 17854601
[TBL] [Abstract][Full Text] [Related]
34. Circadian disruption accelerates liver carcinogenesis in mice.
Filipski E; Subramanian P; Carrière J; Guettier C; Barbason H; Lévi F
Mutat Res; 2009; 680(1-2):95-105. PubMed ID: 19833225
[TBL] [Abstract][Full Text] [Related]
35. Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma.
Lu M; Wu J; He F; Wang XL; Li C; Chen ZN; Bian H
J Mol Histol; 2015 Feb; 46(1):79-91. PubMed ID: 25447507
[TBL] [Abstract][Full Text] [Related]
36. NLRP12 suppresses hepatocellular carcinoma via downregulation of cJun N-terminal kinase activation in the hepatocyte.
Udden SN; Kwak YT; Godfrey V; Khan MAW; Khan S; Loof N; Peng L; Zhu H; Zaki H
Elife; 2019 Apr; 8():. PubMed ID: 30990169
[TBL] [Abstract][Full Text] [Related]
37. Fluoride induces oxidative damage and SIRT1/autophagy through ROS-mediated JNK signaling.
Suzuki M; Bandoski C; Bartlett JD
Free Radic Biol Med; 2015 Dec; 89():369-78. PubMed ID: 26431905
[TBL] [Abstract][Full Text] [Related]
38. Caspase-2 deficiency promotes aberrant DNA-damage response and genetic instability.
Dorstyn L; Puccini J; Wilson CH; Shalini S; Nicola M; Moore S; Kumar S
Cell Death Differ; 2012 Aug; 19(8):1288-98. PubMed ID: 22498700
[TBL] [Abstract][Full Text] [Related]
39. CHK2 overexpression and mislocalisation within mitotic structures enhances chromosomal instability and hepatocellular carcinoma progression.
Carloni V; Lulli M; Madiai S; Mello T; Hall A; Luong TV; Pinzani M; Rombouts K; Galli A
Gut; 2018 Feb; 67(2):348-361. PubMed ID: 28360097
[TBL] [Abstract][Full Text] [Related]
40. Targeting increased copper levels in diethylnitrosamine induced hepatocellular carcinoma cells in rats by epigallocatechin-3-gallate.
Farhan M; Rizvi A; Naseem I; Hadi SM; Ahmad A
Tumour Biol; 2015 Nov; 36(11):8861-7. PubMed ID: 26069106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
